News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmusanT, Inc. Release: New Test In Celiac Disease Provides Powerful Tool For Diagnosis And Immune Monitoring



1/6/2014 9:52:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmusanT, a company focused on restoring tolerance to gluten and overcoming the need for gluten-free diet in patients with celiac disease, today announced that an article appearing in the February 2014 issue of the journal, Clinical & Experimental Immunology, features research findings demonstrating that a simple blood test may eventually be used for diagnosing celiac disease and monitoring new therapies. ImmusanT’s chief scientific officer, Bob Anderson, M.D., Ph.D., along with collaborators in Australia, led the study.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES